Go Deep
MedRx Co., Ltd
MedRx Co., Ltd Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,730 | -3.5 | 2.04 | 0.00 | 29.66 |
| Oct 2026 | 20,730 | -3.5 | 2.04 | 0.00 | 29.61 |
MedRx Co., Ltd Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 6,045,000.0 | 5,680,000.0 | 9,276,000.0 | 100,000,000.0 |
| Net Profit | -312,672,000.0 | -238,376,000.0 | -167,947,000.0 | -139,850,000.0 |
| EPS | — | -4.0 | — | — |
MedRx Co., Ltd Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 128,084,000.0 | 257,915,000.0 | 29,534,000.0 | 59,482,000.0 | — |
| Net Profit | -937,373,000.0 | -806,756,000.0 | -932,897,000.0 | -1,111,150,000.0 | — |
| EPS | -17.4 | -18.6 | -26.8 | -43.8 | — |
MedRx Co., Ltd Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,157,533,000.0 | 2,275,600,000.0 | 2,052,252,000.0 | 1,398,266,000.0 | — |
| Total Liabilities | 108,543,000.0 | 105,602,000.0 | 127,521,000.0 | 185,555,000.0 | — |
| Total Equity | 2,048,990,000.0 | 2,169,998,000.0 | 1,924,731,000.0 | 1,212,711,000.0 | — |
Owes vs Owns
MedRx Co., Ltd owed ¥0.09 for every ¥1 it owned in Jun 2026, down from ¥0.13 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.09× | 0.05× | 0.05× | 0.06× | 0.13× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
MedRx Co., Ltd Assets & Liabilities Breakdown (JPY millions)
What it owns — Dec 2025
Cash & short-term investments 81.3%Inventory 0.8%Fixed assets (tangible) 8.9%Long-term investments 6.1%Other assets 2.9%
How it's funded — Dec 2025
Payables 3.5%Other liabilities 1.5%Shareholders' equity 95.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,754.7 | 1,977.6 | 1,720.7 | 994.0 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 16.9 | 10.0 | 10.1 | 8.3 |
| Fixed assets (tangible) | 192.2 | 123.7 | 181.5 | 226.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 130.9 | 31.2 | 0.0 | 0.0 |
| Other assets | 62.8 | 133.1 | 139.9 | 169.6 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 75.9 | 104.0 | 98.5 | 156.5 |
| Other liabilities | 32.6 | 1.6 | 29.0 | 29.0 |
| Shareholders' equity | 2,049.0 | 2,170.0 | 1,924.7 | 1,212.7 |
| Net tangible assets | 2,049.0 | 2,170.0 | 1,924.7 | 1,212.7 |
MedRx Co., Ltd Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -888,109,000.0 | -803,403,000.0 | -913,800,000.0 | -1,073,292,000.0 | — |
| Investing Activities | -82,752,000.0 | -3,155,000.0 | -759,000.0 | -1,958,000.0 | — |
| Financing Activities | 745,093,000.0 | 1,066,994,000.0 | 1,639,492,000.0 | 356,315,000.0 | — |